Metraipolis › archive › dc_3f499f4cc024

A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2):… — Europe PMC PMID:42934585

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42934585
DOI
10.1186/s12885-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-01T07:56:45.404Z
SHA-256 of the archived text
9338638e4af5f4f0d51c427b9b343021f9bb1841610cfeae6d1cc00319e4cdf4
Stable URL of this page
https://metraipolis.com/documento/dc_3f499f4cc024

How to cite

A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2):… — Europe PMC PMID:42934585 — Europe PMC (en), https://europepmc.org/article/MED/42934585 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f499f4cc024 (Metraipolis archive dc_3f499f4cc024, sha256 9338638e4af5f4f0d51c427b9b343021f9bb1841610cfeae6d1cc00319e4cdf4)
BibTeX
@misc{dc3f499f4cc024,
  title = {A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2):… — Europe PMC PMID:42934585},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42934585},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f499f4cc024; sha256 9338638e4af5f4f0d51c427b9b343021f9bb1841610cfeae6d1cc00319e4cdf4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42934585. Agents can read the archived copy with the MCP tool read_document.